Bioprocess solutions to assess clinical biodistribution in cell/gene therapies
Sign Up to like & getrecommendations! Published in 2020 at "Cytotherapy"
DOI: 10.1016/j.jcyt.2020.03.204
Abstract: Background & Aim Lack of comprehensive product knowledge in clinical applications may result in toxicity or reduced drug efficacy. The distributive fate and retention of cell/gene therapies is rarely evaluated, with very few studies assessing… read more here.
Keywords: biodistribution; product; cell gene; bioprocess solutions ... See more keywords